Clinical Trials The Tricaprilin Relief study in migraine is based on a growing body of scientific evidence suggesting ketone bodies may help prevent migraine attacks.

The exact way this happens is not yet clear, but could be due to addressing deficient brain glucose metabolism that is characteristic of numerous neurological conditions.